Poseida Therapeutics, Inc. Business Finance Contracts & Agreements
25 Contracts & Agreements
- Contribution Agreements (1 contract)
- Investor Rights Agreements (2)
- Loan Agreements (6)
- Participation Agreements (2)
- Purchase Agreements (2)
- Registration Rights Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (1)
- Warrant Agreements (6)
- Consent and First Amendment to Loan and Security Agreement, by and among the Registrant and Oxford Finance LLC, dated July 19, 2023 (Filed With SEC on August 8, 2023)
- Registration Rights Agreement, by and between the Company and Astellas, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Securities Purchase Agreement, by and between the Company and Astellas, dated August 4, 2023 (Filed With SEC on August 7, 2023)
- Purchase Agreement, dated August 3, 2022, by and among Poseida Therapeutics, Inc., Piper Sandler & Co. and William Blair & Company, L.L.C, as representatives of the several... (Filed With SEC on August 4, 2022)
- Loan and Security Agreement, by and among the Registrant, Vindico NanoBioTechnology, LLC and Oxford Finance LLC, dated February 22, 2022 (Filed With SEC on March 10, 2022)
- Amended and Restated Participation Agreement, by and between the Company and Eric Ostertag, M.D., Ph.D., dated February 1, 2022 (Filed With SEC on February 1, 2022)
- Amended and Restated Participation Agreement, by and between the Company and Mark Gergen, dated February 1, 2022 (Filed With SEC on February 1, 2022)
- Fifth Amendment to Loan and Security Agreement, by and among the Registrant, Vindico NanoBioTechnology, LLC and Oxford Finance LLC, dated June 24, 2021 (Filed With SEC on August 12, 2021)
- Description of Common Stock (Filed With SEC on March 11, 2021)
- Loan and Security Agreement, by and among the Registrant, Vindico NanoBioTechnology, LLC and Oxford Finance LLC, dated July 25, 2017, as amended on May 15, 2018, August 13, 2018,... (Filed With SEC on July 6, 2020)
- Poseida Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on July 6, 2020)
- Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated June 24, 2020 (Filed With SEC on July 6, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 6, 2020)
- Loan and Security Agreement, by and among the Registrant, Vindico NanoBioTechnology, LLC and Oxford Finance LLC, dated July 25, 2017, as amended on May 15, 2018, August 13, 2018... (Filed With SEC on June 19, 2020)
- Form of Warrant issued to Oxford Finance LLC, dated February 11, 2019 (Filed With SEC on June 19, 2020)
- Form of Warrant issued to Oxford Finance LLC, dated August 13, 2018 (Filed With SEC on June 19, 2020)
- Form of Warrant issued to Oxford Finance LLC, dated July 25, 2017 (Filed With SEC on June 19, 2020)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on June 19, 2020)
- Form of Warrant issued to Oxford Finance LLC, dated February 11, 2019 (Filed With SEC on March 4, 2019)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on March 4, 2019)
- Loan and Security Agreement, by and among the Registrant, Vindico NanoBioTechnology LLC and Oxford Finance LLC, dated July 25, 2017, as amended on May 15, 2018, August 13, 2018... (Filed With SEC on January 4, 2019)
- Form of Warrant issued to Oxford Finance LLC, dated August 13, 2018 (Filed With SEC on January 4, 2019)
- Form of Warrant issued to Oxford Finance LLC, dated July 25, 2017 (Filed With SEC on January 4, 2019)
- Amended and Restated Investors Rights Agreement, by and between the Registrant and certain of its stockholders, dated March 19, 2018 (Filed With SEC on January 4, 2019)
- Asset Contribution Agreement, by and between the Registrant and Transposagen Biopharmaceuticals, Inc., dated February 9, 2015 (Filed With SEC on January 4, 2019)
